|
"It might be too soon to call this "medicine," a word with certain emotional associations. The article includes many interesting and intriguing anecdotes, but to date the described effects haven't been examined in a properly designed double-blind study" The history of medicine is full of examples of treatments being tested in the clinic long before any double-blind tests are made. Things like the first use of anesthetic spring to mind. If they had waited for double-blind studies that would have satisfied modern science, millions of people would have suffered for another hundred years without it. The practice of testing treatments in the clinic continues to this day, with doctors prescribing medicines for off-label uses, and with even psychedelics being used in psychedelic therapy by psychologists brave enough to risk their careers and freedom to help people. Ideally there would be double-blind studies on everything, but those studies cost an enormous amount of money, and in the case of psychedelics have to overcome enormous political hurdles. The cost rises astronomically when we're talking about large, statistically significant double-blind studies. Furthermore, since a lot of psychedelics, like mushrooms and peyote, can be ingested directly from plants, and many others like LSD have long been out of patent protection, most pharmaceutical companies (which are usually the only ones with pockets deep enough to fund these kinds of studies) aren't interested, as they won't make a profit on something so easily available from other sources than themselves. That's not to mention the political hot potato of psychedelic research as a whole, which is still regarded with suspicion by much of the medical and political establishment. |